Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

540 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent trends of low-density lipoprotein cholesterol control and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Taiwan: 2015-2020.
Chen TY, Hsiao YC, Wu YW, Lin TH, Sheu WH, Lee TL, Hsieh IC, Li YH, Yin WH, Yeh HI, Chen JW, Lin FJ, Wu CC. Chen TY, et al. Among authors: sheu wh. J Formos Med Assoc. 2024 Oct 24:S0929-6646(24)00486-8. doi: 10.1016/j.jfma.2024.10.010. Online ahead of print. J Formos Med Assoc. 2024. PMID: 39455400 Free article.
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment.
Li YH, Tseng WK, Yin WH, Lin FJ, Wu YW, Hsieh IC, Lin TH, Sheu WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators. Li YH, et al. Among authors: sheu wh. Sci Rep. 2020 Dec 14;10(1):21835. doi: 10.1038/s41598-020-78828-8. Sci Rep. 2020. PMID: 33318590 Free PMC article. Clinical Trial.
Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan.
Liu PY, Lin FJ, Yeh CF, Hsiao YC, Hsuan CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WH, Li YH, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary and Primary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE & T-PPARCLE) Registries Investigators. Liu PY, et al. Among authors: sheu wh. J Clin Med. 2023 Mar 10;12(6):2162. doi: 10.3390/jcm12062162. J Clin Med. 2023. PMID: 36983164 Free PMC article.
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
Chiang CE, Lin SY, Lin TH, Wang TD, Yeh HI, Chen JF, Tsai CT, Hung YJ, Li YH, Liu PY, Chang KC, Wang KL, Chao TH, Shyu KG, Yang WS, Ueng KC, Chu PH, Yin WH, Wu YW, Cheng HM, Shin SJ, Huang CN, Chuang LM, Lin SJ, Yeh SJ, Sheu WH, Lin JL. Chiang CE, et al. Among authors: sheu wh. J Chin Med Assoc. 2018 Mar;81(3):189-222. doi: 10.1016/j.jcma.2018.01.001. Epub 2018 Feb 13. J Chin Med Assoc. 2018. PMID: 29453020 Free article.
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study.
Hsiao YC, Lee TL, Lin FJ, Hsuan CF, Yeh CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WH, Li YH, Yin WH, Yeh HI, Chen JW, Wu CC; Taiwanese Secondary and Primary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE & T-PPARCLE) Registries Investigators. Hsiao YC, et al. Among authors: sheu wh. Biomed J. 2024 Jun;47(3):100653. doi: 10.1016/j.bj.2023.100653. Epub 2023 Aug 12. Biomed J. 2024. PMID: 37579816 Free PMC article.
Pay-for-performance for shared care of diabetes in Taiwan.
Lee IT, Hsu CC, Sheu WH, Su SL, Wu YL, Lin SY. Lee IT, et al. Among authors: sheu wh. J Formos Med Assoc. 2019 Nov;118 Suppl 2:S122-S129. doi: 10.1016/j.jfma.2019.08.011. Epub 2019 Aug 27. J Formos Med Assoc. 2019. PMID: 31471222 Free article.
540 results